Lifeward CMO reports 2,083 share stake

Lifeward Ltd. Chief Medical Officer Rose Keith Dale filed an initial Form 3 reporting her equity position in the company.

Rhea-AI Filing Summary

Lifeward Ltd. Chief Medical Officer Rose Keith Dale filed an initial Form 3 reporting her equity position in the company. The filing lists direct ownership of 2,083 ordinary shares of no par value as of May 1, 2026, and does not report any share purchases or sales.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Rose Keith Dale

Role Chief Medical Officer

Type	Security	Shares	Price	Value
holding	Ordinary Shares, no par value per share	--	--	--

Holdings After Transaction: Ordinary Shares, no par value per share — 2,083 shares (Direct)

Key Figures

Ordinary shares held: 2,083 shares Form type: Form 3 Insider role: Chief Medical Officer

3 metrics

Ordinary shares held 2,083 shares Direct ownership as of May 1, 2026

Form type Form 3 Initial statement of beneficial ownership by officer

Insider role Chief Medical Officer Reporting person’s position at Lifeward Ltd.

Key Terms

Ordinary Shares, no par value per share, Form 3, Chief Medical Officer

3 terms

Ordinary Shares, no par value per share financial

"security_title: Ordinary Shares, no par value per share"

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Chief Medical Officer financial

"officer_title: Chief Medical Officer"

A chief medical officer is a senior executive responsible for overseeing the health and medical strategies within an organization, often in the healthcare or pharmaceutical sectors. They play a key role in guiding decisions related to medical research, product safety, and healthcare policies, which can impact a company's reputation and success. For investors, understanding the chief medical officer's role helps gauge how well a company manages medical risks and advances its healthcare goals.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Lifeward (LFWD) Chief Medical Officer Rose Keith Dale report in this Form 3?

The Form 3 shows that Chief Medical Officer Rose Keith Dale directly owns 2,083 ordinary shares of Lifeward Ltd. It is an initial ownership report, establishing her starting equity position as an officer of the company.

How many Lifeward (LFWD) shares does Rose Keith Dale beneficially own according to the Form 3?

According to the Form 3, Rose Keith Dale directly holds 2,083 ordinary shares of Lifeward Ltd. These ordinary shares have no par value per share and represent her reported ownership as of the filing’s referenced date.

Does the Lifeward (LFWD) Form 3 for Rose Keith Dale show any recent share purchases or sales?

No, the Form 3 does not show any purchases or sales of Lifeward shares. It records a holding entry only, listing 2,083 ordinary shares directly owned, with no transaction price or trade volume disclosed in the filing data.

What type of security is reported in Rose Keith Dale’s Form 3 for Lifeward (LFWD)?

The Form 3 reports ownership of Ordinary Shares, no par value per share of Lifeward Ltd. This indicates standard equity in the company rather than options or other derivative securities, with no separate exercise or expiration terms listed.

What is Rose Keith Dale’s role at Lifeward (LFWD) as disclosed in the Form 3?

The Form 3 identifies Rose Keith Dale as an officer of Lifeward Ltd., serving as Chief Medical Officer. This role typically oversees the company’s medical or clinical functions and is significant for leadership and regulatory disclosures.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/20/2026 - 08:13 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Rose Keith Dale

(Last) (First) (Middle)

C/O LIFEWARD LTD.

2 CABOT ROAD

(Street)

HUDSON MASSACHUSETTS 01749

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/01/2026

3. Issuer Name and Ticker or Trading Symbol
Lifeward Ltd. [ LFWD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares, no par value per share	2,083	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24.1 - Power of Attorney

	/s/ Almog Adar, as Attorney-in-Fact	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)